Researchers conducted a nationwide cohort study using data from the Taiwan National Health Insurance database and the Taiwan ...

Congress supporting ESK-001’s potential to offer a differentiated and best-in-class treatment profile for people with moderate-to-severe plaque psoriasis: Late-breaking 28-week data from the Open ...

The treatment worked so well that her tumor shrank by more than ... and in four the volume of tumors were reduced by at least ...

Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

A dermatophyte known as Trichophyton mentagrophytes genotype VII (TMVII) has been identified as the cause of an emerging ...

If your scalp’s been bugging you with that all-day itch, the best shampoo for itchy scalps can offer a temporary respite ...

Whatever TikTok trends or buzzy skin-care ingredients are out there, heed this piece of advice: Don't compromise your barrier ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic ... received Glamour’s 2024 Health and Wellness award for Best ...

Fish and lean protein, fruits and vegetables, legumes, nuts and seeds, olive oil, small amounts of low-fat dairy, and whole ...

In an as-started analysis, the risk for psoriasis among patients with stage III/IV cancers was two- to three-fold higher among ICI users when compared against controls who received chemotherapy or ...